Gallbladder Empyema
Gallbladder Empyema
Gallbladder Empyema
Left untreated, generalized sepsis ensues, with progression in the gallbladder to patchy gangrene,
microperforation, macroperforation, or, rarely, cholecystoduodenal fistula
Patients at increased risk for cholecystitis include those with diabetes, immunosuppression, obesity, or
hemoglobinopathies
Etiology
Unresolved acute calculous cholecystitis in the face of contaminated bile
The most frequently isolated organisms include Escherichia coli, Klebsiella pneumoniae, Streptococcus
faecalis, and anaerobes, including Bacteroides and Clostridia species
Suppurative inflammation ensues, tightly filling the gallbladder with purulent debris
Localized or free perforation occurs if drainage or resection is not performed at this juncture.
Rarely, obstruction of the distal common bile duct may result in pus formation within the extrahepatic
biliary tree, which can then decompress into the gallbladder
Epidemiology
International
incidence of empyema of the gallbladder associated with acute cholecystitis, findings from limited series indicate a
range of 5-15%.
Race-related Demographics
American Indians and Central American Indians have an increased risk of cholelithiasis/cholecystitis, as do patients
with hemoglobinopathies, such as sickle cell anemia (more likely in black persons).
Prognosis
If treated early, otherwise healthy patients have a full recovery and return to normal activity.
In patients of advanced age, those who are immunocompromised, or those with significant comorbid
conditions, the development of empyema of the gallbladder and the resultant sepsis constitute a serious life-
threatening event
The postoperative complication rate (regardless of approach) for empyema of the gallbladder is 10-20% and
includes wound infection, bleeding, subhepatic abscess, cystic stump leak, common bile duct injury, and
systemic complications
Progression to death is unusual in otherwise healthy individuals but may occur in patients of advanced age
History
The clinical history of a patient with empyema of the gallbladder is similar to that of a patient with acute
cholecystitis (from which the empyema derives)
As the disease progresses, severe pain and associated high fever, chills, and even rigors may be reported
Patients with diabetes or immunosuppression may exhibit few signs and symptoms.
Physical Examination
Present no differently than any patient with acute cholecystitis, with symptoms that include fever
(temperature, >101°F), stable blood pressure, and mild tachycardia.
If localized or free perforation has occurred and/or the patient has generalized sepsis, fevers (temperature,
103°F), chills and/or rigors, and confusion may be observed in association with hypotension and severe
tachycardia.\
Mild-to-moderate tenderness in the right upper abdomen and a positive Murphy sign
As the disease progresses, empyema of the gallbladder may be associated with a palpable distended
gallbladder that is markedly tender on even superficial palpation.
Differential Diagnosis
Cholecystitis
Cholelithiasis
Laboratory Studies
Increasing leukocytosis at levels greater than 15,000/dL
This scenario may occur in association with gangrenous cholecystitis and with several other differential
diagnoses
When arising from complicated acute cholecystitis, liver chemistry findings associated with empyema of the
gallbladder are usually within reference ranges,
One exception is empyema of the gallbladder in which the enlarged "penile" gallbladder compresses the
common/hepatic bile ducts (Mirizzi syndrome), giving rise to mildly elevated alkaline phosphatase and
bilirubin levels.
Serial blood cultures are beneficial in patients with bacteremia; positive results help direct antibiotic therapy
Imaging Studies
Ultrasonography of the gallbladder is indicated in presumed empyema of the
gallbladder
Histologic findings include a pus-filled gallbladder, with or without calculi, and an acute suppuration of
the gallbladder wall, with or without areas of gangrene and perforation.
Medical Care
Intravenous antibiotic therapy is an adjunct to urgent decompression and/or resection of the gallbladder when empyema is
likely
Early in the course of the disease, good results are achieved with the adjuvant administration of a second-generation
cephalosporin
More advanced cases associated with perforation and/or generalized sepsis, broader spectrum coverage with piperacillin
tazobactam is advised.
In patients who are hemodynamically unstable or in individuals in whom surgery is contraindicated because of significant
comorbid conditions
Transhepatic drainage of the gallbladder under radiologic guidance may serve as a temporizing or final procedure
Surgical Care
Surgical decompression and resection of the affected gallbladder is the criterion standard of therapy
An advanced laparoscopic surgeon may treat empyema of the gallbladder (without significant gangrenous
changes or perforation) with a laparoscopic procedure.
Initial decompression may be accomplished under radiographic guidance immediately before the procedure or
via intraoperative, laparoscopically guided needle drainage
The conversion-to-open and complication rates reported in the literature for laparoscopic treatment of
empyema vary widely.
The conversion-to-open and complication rates reported in the literature for laparoscopic treatment of
empyema vary widely.
Medication Summary
The goals of pharmacotherapy are to reduce morbidity and to prevent complications.
Resists degradation by beta-lactamase; proper dosing and appropriate route of administration are
determined by condition of patient, severity of infection, and susceptibility of microorganism
Penicillins, Extended-Spectrum
Piperezacilin tazobakram
1. Inhibits biosynthesis of cell wall mucopeptide synthesis by binding to 1 or
more of the penicillin-binding proteins and is effective during active-
multiplication stage.
TERIMA KASIH